Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR3 | P51677 | 12/20 | 0.67 |
| ▸ | HRH1 | P35367 | 11/20 | 0.52 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CCR2 | P41597 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL5656763 | 0.90 | CCR3 (0.68) | CCR3HRH1SLC5A7KCNH2NPC1 | |
| Hydrochloric Acid SCHEMBL5656041 | 0.86 | CCR3 (0.75) | CCR3HRH1SLC5A7KCNH2NPC1 | |
| SCHEMBL5657206 | 0.85 | CCR3 (0.73) | CCR3HRH1SLC5A7KCNH2CCR2 | |
| Acetic Acid SCHEMBL5657504 | 0.85 | CCR3 (0.70) | CCR3HRH1SLC5A7KCNH2CCR2 | |
| SCHEMBL5657115 | 0.82 | CCR3 (0.73) | CCR3HRH1SLC5A7KCNH2NPC1 | |
| SCHEMBL6396375 | 0.81 | CCR3 (0.81) | CCR3HRH1SLC5A7KCNH2MEN1 | |
| Hydrochloric Acid SCHEMBL5658390 | 0.81 | CCR3 (0.67) | CCR3HRH1SLC5A7KCNH2NPC1 | |
| SCHEMBL6397066 | 0.81 | CCR3 (0.81) | CCR3HRH1SLC5A7KCNH2NPC1 | |
| SCHEMBL5658825 | 0.81 | CCR3 (1.00) | CCR3HRH1SLC5A7KCNH2 | |
| SCHEMBL13177087 | 0.81 | CCR3 (0.66) | CCR3HRH1SLC5A7KCNH2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7304077-B2 | Chemical compounds | ASTRAZENECA AB (SE) | 2007-12-04 | — | — | US | disclosed |
| US-20040102432-A1 | Chemical compounds | ASTRAZENECA AB (SE) | 2004-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102432-A1 | Chemical compounds | CCL11, HRH1, HRH4 | CCR3 17/4885HRH1 2/4885SLC5A7 1670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.